4.4 Review

THERAPEUTICS DEVELOPMENT IN MYOTONIC DYSTROPHY TYPE 1

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy

Hong M. Moulton et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2010)

Review Biochemistry & Molecular Biology

Progress in therapeutic antisense applications for neuromuscular disorders

Annemieke Aartsma-Rus et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2010)

Article Biochemistry & Molecular Biology

Analysis of CUGBP1 Targets Identifies GU-Repeat Sequences That Mediate Rapid mRNA Decay

Bernd Rattenbacher et al.

MOLECULAR AND CELLULAR BIOLOGY (2010)

Editorial Material Biochemistry & Molecular Biology

Muscling in Gene therapies for muscular dystrophy target RNA

Joel R. Chamberlain et al.

NATURE MEDICINE (2010)

Review Cell Biology

Repeat instability as the basis for human diseases and as a potential target for therapy

Arturo Lopez Castel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)

Article Biochemistry & Molecular Biology

Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy

Hongqing Du et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)

Article Clinical Neurology

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1

E. L. Logigian et al.

NEUROLOGY (2010)

Article Biochemistry & Molecular Biology

Rational and Modular Design of Potent Ligands Targeting the RNA That Causes Myotonic Dystrophy 2

Melissa M. Lee et al.

ACS CHEMICAL BIOLOGY (2009)

Article Clinical Neurology

Paternally inherited case of congenital DM1: Brain MRI and review of literature

Alfonso Di Costanzo et al.

BRAIN & DEVELOPMENT (2009)

Review Psychology, Developmental

Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy

Marie Douniol et al.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2009)

Article Biochemistry & Molecular Biology

Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides

Paul J. White et al.

EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)

Article Medicine, Research & Experimental

PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1

Guey-Shin Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2009)

Article Orthopedics

Orthopaedic Manifestations of Congenital Myotonic Dystrophy During Childhood and Adolescence

Federico Canavese et al.

JOURNAL OF PEDIATRIC ORTHOPAEDICS (2009)

Article Neurosciences

Absence of a differentiation defect in muscle satellite cells from DM2 patients

Richard Pelletier et al.

NEUROBIOLOGY OF DISEASE (2009)

Article Multidisciplinary Sciences

A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding

Jonathan F. Arambula et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Pentamidine reverses the splicing defects associated with myotonic dystrophy

M. Bryan Warf et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy

Susan A. M. Mulders et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA

Thurman M. Wheeler et al.

SCIENCE (2009)

Article Biochemistry & Molecular Biology

Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1

Irina A. Vlasova et al.

MOLECULAR CELL (2008)

Article Clinical Neurology

Dehydroepiandrosterone for myotonic dystrophy type 1

I. Penisson-Besnier et al.

NEUROLOGY (2008)

Review Neurosciences

Myotonic disorders

Ami Mankodi

NEUROLOGY INDIA (2008)

Article Multidisciplinary Sciences

Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy

James P. Orengo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Neurosciences

Myotonic dystrophy 1 in the nervous system: From the clinic to molecular mechanisms

Mario Bermudez de Leon et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2008)

Review Biotechnology & Applied Microbiology

MicroRNAs in disease and potential therapeutic applications

Harris S. Soifer et al.

MOLECULAR THERAPY (2007)

Article Biochemistry & Molecular Biology

A small molecule microarray platform to select RNA internal loop-ligand interactions

Jessica L. Childs-Disney et al.

ACS CHEMICAL BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Increased steady-state in levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation

N. Muge Kuyumcu-Martinez et al.

MOLECULAR CELL (2007)

Article Biochemistry & Molecular Biology

Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets

Jacelk Krol et al.

MOLECULAR CELL (2007)

Review Clinical Neurology

Cerebral involvement in myotonic dystrophies

Giovanni Meola et al.

MUSCLE & NERVE (2007)

Article Respiratory System

Sleep disorders in neuromuscular diseases

Upinder K. Dhand et al.

CURRENT OPINION IN PULMONARY MEDICINE (2006)

Article Genetics & Heredity

Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy

Mani S. Mahadevan et al.

NATURE GENETICS (2006)

Article Neurosciences

ETR-3 represses tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I

Olivier Leroy et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2006)

Article Multidisciplinary Sciences

Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy

Rahul N. Kanadia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Biotechnology & Applied Microbiology

Chemical modifiers of unstable expanded simple sequence repeats: What goes up, could come down

Mario Gomes-Pereira et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)

Article Biochemistry & Molecular Biology

Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1

O Leroy et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)

Article Genetics & Heredity

Anatomy of a founder effect:: myotonic dystrophy in Northeastern Quebec

V Yotova et al.

HUMAN GENETICS (2005)

Article Biochemistry & Molecular Biology

Small-molecule ligand induces nucleotide flipping in (CAG)n trinucleotide repeats

K Nakatani et al.

NATURE CHEMICAL BIOLOGY (2005)

Article Biochemistry & Molecular Biology

Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells

MA Langlois et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Muscleblind proteins regulate alternative splicing

TH Ho et al.

EMBO JOURNAL (2004)

Article Genetics & Heredity

Insulin receptor splicing alteration in myotonic dystrophy type 2

RS Savkur et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2004)

Review Genetics & Heredity

Myotonic dystrophy: RNA pathogenesis comes into focus

LPW Ranum et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2004)

Article Multidisciplinary Sciences

A muscleblind knockout model for myotonic dystrophy

RN Kanadia et al.

SCIENCE (2003)

Article Biotechnology & Applied Microbiology

Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts

MA Langlois et al.

MOLECULAR THERAPY (2003)

Article Biochemistry & Molecular Biology

Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions

D Furling et al.

GENE THERAPY (2003)

Article Clinical Neurology

Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2

A Mankodi et al.

ANNALS OF NEUROLOGY (2003)

Article Biochemistry & Molecular Biology

Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2

A Mankodi et al.

HUMAN MOLECULAR GENETICS (2001)

Article Multidisciplinary Sciences

Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9

CL Liquori et al.

SCIENCE (2001)

Article Multidisciplinary Sciences

Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat

A Mankodi et al.

SCIENCE (2000)